Kenya vs Uganda: The number of people with susceptibility test result for rifampicin
Kenya
24,832
in 2021
Uganda
28,418
in 2021
Kenya rank
13th
Uganda rank
11th
The number of people with susceptibility test result for rifampicin over time
- Kenya
- Uganda
How they compare
Uganda currently reports 28,418 against 24,832 in Kenya, a difference of 3,586.
That makes Uganda's figure about 1.1 times Kenya's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Kenya ahead.
Kenya ranks 13th and Uganda ranks 11th of 155 countries.
Kenya has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kenya | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 29,916 | 23,037 | 6,880 | Kenya |
| 2020s | 28,802 | 23,910 | 4,892 | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Kenya or Uganda?
- Uganda, at 28,418 against 24,832 in Kenya as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Kenya and Uganda?
- 3,586, with Uganda ahead.
- How many years of comparable data are there for Kenya and Uganda?
- 5 years are reported by both, from 2017 to 2021.
- How do Kenya and Uganda rank globally for the number of people with susceptibility test result for rifampicin?
- Kenya ranks 13th and Uganda ranks 11th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.